Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy
- 20 January 2012
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Chemical Neuroscience
- Vol. 3 (3) , 221-236
Abstract
Herein we present the outcome of a high throughput screening (HTS) campaign-based strategy for the rapid identification and optimization of selective and general chemotypes for both kappa (κ) opioid receptor (KOR) activation and inhibition. In this program, we have developed potent antagonists (IC50 < 120 nM) or agonists of high binding affinity (Ki < 3 nM). In contrast to many important KOR ligands, the compounds presented here are highly modular, readily synthesized, and, in most cases, achiral. The four new chemotypes hold promise for further development into chemical tools for studying the KOR or as potential therapeutic lead candidates.Keywords
This publication has 32 references indexed in Scilit:
- Academic cross-fertilization by public screening yields a remarkable class of protein phosphatase methylesterase-1 inhibitorsProceedings of the National Academy of Sciences, 2011
- PubChem as a public resource for drug discoveryDrug Discovery Today, 2010
- Seven Transmembrane Receptors as Shapeshifting Proteins: The Impact of Allosteric Modulation and Functional Selectivity on New Drug DiscoveryPharmacological Reviews, 2010
- The NIH Molecular Libraries Program: Identifying Chemical Probes for New MedicinesChemistry & Biology, 2010
- Probing the Probes: Fitness Factors For Small Molecule ToolsChemistry & Biology, 2010
- Current perspectives on selective dopamine D3receptor antagonists as pharmacotherapeutics for addictions and related disordersAnnals of the New York Academy of Sciences, 2010
- Kappa-opioid ligands in the study and treatment of mood disordersPharmacology & Therapeutics, 2009
- Synthesis of some substituted 1,2,4-triazole and 1,3,4-thiadiazole derivativesChemistry of Heterocyclic Compounds, 2008
- Long-Acting κ Opioid Antagonists Disrupt Receptor Signaling And Produce Noncompetitive Effects By Activating C-Jun N-Terminal KinaseJournal of Biological Chemistry, 2007
- A β-Arrestin/Green Fluorescent Protein Biosensor for Detecting G Protein-coupled Receptor ActivationJournal of Biological Chemistry, 1997